GlassScriptPhysician profile
Nehal Patel
NPI 1265012231
$4,048.70
in general payments reported to CMS, 2019-2025
28 companies · $2,465 in 2025
The $2,465 reported for 2025 was more than what 95% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $521 · 2024: $1,063 · 2025: $2,465.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,049.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,048.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aop Health US, LLC | $859.69 | 2025 | Rapiblyk |
| Astrazeneca Pharmaceuticals LP | $574.65 | 2023-2025 | Farxiga, Lokelma, Wainua |
| Amgen INC. | $374.34 | 2023-2025 | Repatha, Repatha |
| Novartis Pharmaceuticals Corporation | $369.92 | 2024-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $288.23 | 2023-2025 | Jardiance |
| Merck Sharp & Dohme LLC | $228.19 | 2023-2025 | Verquvo |
| Pfizer INC. | $173.56 | 2023-2025 | |
| Esperion Therapeutics, INC. | $116.36 | 2024-2025 | Nexletol |
| Scpharmaceuticals INC. | $114.75 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $104.70 | 2024-2025 | Lifevest |
| Kestra Medical Technology Services, INC. | $97.19 | 2025 | Assure Wcd |
| Kiniksa Pharmaceuticals International, Plc | $96.33 | 2024 | Arcalyst |
| Medtronic, INC. | $92.34 | 2023-2025 | Apollotm, Micra, Venaseal |
| Boston Scientific Corporation | $90.72 | 2023-2025 | Watchman Flx |
| Alnylam Pharmaceuticals INC. | $60.61 | 2025 | Amvuttra |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $58.30 | 2023-2024 | Rybelsus, Ozempic |
| Bayer Healthcare Pharmaceuticals INC. | $54.64 | 2025 | |
| Biosense Webster, INC. | $54.17 | 2023-2025 | Carto 3, Qdot Micro Catheter |
| Actelion Pharmaceuticals US, INC. | $32.49 | 2024 | Opsumit |
| E.R. Squibb & Sons, L.L.C. | $31.07 | 2023-2025 | Camzyos, Eliquis |
| Philips North America LLC | $28.54 | 2025 | Extended Holter |
| Janssen Pharmaceuticals, INC | $24.01 | 2023 | Xarelto |
| Abbott Laboratories | $22.88 | 2025 | Mitraclip |
| Regeneron Healthcare Solutions, INC. | $22.59 | 2025 | Evkeeza |
| Cvrx, INC. | $22.05 | 2025 | Barostim Neo System |
| Inspire Medical Systems, INC. | $21.74 | 2025 | Inspire |
| Atricure, INC. | $18.21 | 2024 | |
| Innovation Technologies INC | $16.43 | 2025 | Irrisept |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nehal Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.